COMMUNIQUÉS West-GlobeNewswire

KFSHRC Launches Precision Medicine Services in Family Medicine Clinics to Enhance Access to the Latest Genetic Tests

16/01/2025 - 10:52

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched precision medicine services within its Family Medicine Clinics, aiming to advance [...]

Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

16/01/2025 - 09:00

Fabio Dorigotti brings over 25 years of clinical development experience Joins Actimed following retirement of Frank Misselwitz London, UK – 16 January 2025. Actimed Therapeutics, a UK based clinical stage speciality [...]

Phonak expands award-winning Infinio portfolio with two new custom hearing aids

16/01/2025 - 08:00

Phonak, a leading global provider of life-changing hearing solutions, is proud to announce the expansion of its highly acclaimed Infinio technology platform with the introduction of two new in-the-ear (ITE) hearing aids [...]

Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

16/01/2025 - 07:00

Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarter Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that the National Institute [...]

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76

14/01/2025 - 22:58

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ [...]

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue

14/01/2025 - 22:15

Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring revenue expected to be [...]

Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

14/01/2025 - 22:15

FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance [...]

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

14/01/2025 - 22:05

Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Revenue of $68.2 to $68.7 Million Highest Quarterly MACI Implants [...]

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14/01/2025 - 22:05

BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified [...]

Evaxion announces completion of ADS ratio change

14/01/2025 - 22:05

COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that [...]

OP Solutions Appoints Michael Kallish as Chief Executive Officer

14/01/2025 - 20:00

Experienced HIT Executive to Lead Next Stage of Growth for Orthotic & Prosthetic EMR Provider Tampa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- OP Solutions , the emerging leader in comprehensive technology solutions for [...]

UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

14/01/2025 - 19:59

U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccines SAN FRANCISCO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

14/01/2025 - 18:00

Déclaration de transactions sur actions propres Paris, France (14 janvier 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 7 janvier 2025 [...]

Report on Carbios’ liquidity contract with Natixis ODDO BHF

14/01/2025 - 18:00

Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 14 January 2025 (6:00 pm CET). CARBIOS , (Euronext Growth Paris: ALCRB), a pioneer in the [...]

CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF

14/01/2025 - 18:00

Titre concerné : CARBIOS (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 14 janvier 2025 (18h00 CET). CARBIOS, (Euronext Growth Paris : ALCRB), pionnière dans le [...]

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option

14/01/2025 - 18:00

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024

14/01/2025 - 18:00

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]

Vivid Health Joins Kno2 Network to Revolutionize Post-Acute Care

14/01/2025 - 17:02

Enhanced connectivity will bolster Vivid Health’s AI-assisted platform BOISE, Idaho, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Kno2, the company leading the future of healthcare communication, announced today a partnership with [...]

Conceivable Life Sciences Closes $18 Million Series A Financing to Advance Development and Commercialization of the World’s First AI-Powered Automated IVF Lab

14/01/2025 - 15:30

ARTIS Ventures led the financing with participation from new and existing investors, raising over $39 million to date Funds will support ongoing commercial pilot program in Mexico City and preparations for U.S. launch [...]